Bliss GVS Pharma appoints two new Independent Directors

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.9%1-day move

₹234.80

prior close

₹235.09

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.9-2.1-2.1-0.4+0.9+8.0+8.2+10.3+11.2+10.6+15.8+14.1+79.5+108.7

Up moveDown movePending

AI summary

Bliss GVS Pharma's Board, via circular resolution on April 03, 2026, appointed Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah as Additional Non-Executive Independent Directors for 5-year terms (April 03, 2026 to April 02, 2031). Mr. Mahadevan is a Chartered Accountant with 35+ years of finance leadership at Alcon, Sandoz, Novartis, and SHV Energy. Mr. Shah is a Fellow CA with 36+ years in tax and audit, currently serving on boards of Ruby Mills, Marathon Nextgen Realty, and Siyaram Silk Mills. A Postal Ballot will seek shareholder approval.

Likely market impact

Strengthens board with experienced finance and tax professionals; pending shareholder approval via Postal Ballot.